LGALS8 and melanoma: Our observations align with recent studies showing that the tandem-repeat galectin Gal-8 preferentially binds to melanoma cells with reduced GCNT2/I-branching and elevated levels of i-linear poly-LacNAcs, resulting in enhanced activity of pro-tumorigenic signaling pathways [14].